Written by: Kong Fanxu and Zhu Haiqi
The last update date: 2021-03-31 15:47
Hong Kong's new crown pneumonia vaccination program is now underway. The "Fubitai" developed by Fosun/German pharmaceutical company BioNTech had earlier temporarily suspended vaccination due to defective packaging of some batches.
According to news, Hong Kong will resume vaccination with "Fubitai" as soon as early next week.
Guo Guangchang, chairman of Fosun International, also revealed in an interview with foreign news agencies that the "Fubitai" vaccination will be resumed before the weekend or early next week.
In addition, it is understood that the new batch of Fubitai vaccine will be shipped to Hong Kong. It is expected that it will depart from the local area tomorrow, German time, and if everything goes well, it will arrive in Hong Kong on Friday (2nd).
According to sources, the new batch of Fubitai vaccine will arrive in Hong Kong from Germany tomorrow and is expected to arrive in Hong Kong on Friday (2nd).
It is reported that Hong Kong will resume vaccination with Fubitai early next week.
According to Bloomberg News, Fosun International Chairman Guo Guangchang said that Hong Kong may resume vaccination with BioNTech's new crown vaccine before the weekend or early next week.
Guo Guangchang said that due to some flaws in the packaging, vaccination was suspended out of caution, but he was confident in the development of the vaccine business.
The Hong Kong government received a notification from Fosun/BioNTech on the 24th of this month that the packaging of "Fobitai Vaccine" was defective. The Hong Kong government urgently halted the Fubitai vaccination program and the supplier has also withdrawn all defective vaccines.
According to the preliminary investigation submitted by the supplier to the Hong Kong government earlier, it has not been found that there are any significant systemic factors that may cause packaging defects in the process of vaccine packaging from packaging to use, but environmental factors during long-distance transportation cannot be ruled out. , Comprehensive data believe that it is not related to cold chain and logistics management.
▼On March 10, the first day of Fubitai vaccine, the situation of the Zhongshan Memorial Park Gymnasium vaccination center▼
Fubitai vaccine suspension | Lin Zhexuan: If Fosun does not submit a report today, it will be difficult to vaccinate next Monday
Fubitai｜Fosun BioNTech vaccine has cracks and loosening in the medicine bottle, and 150,000 doses have been delivered
Fosun Fubitai suspends | 150,000 people have received the first dose of He Boliang: the second dose will be given on the 42nd at the latest
Fosun Fubitai suspends vaccination｜The first injection has been given and 5 notices for citizens to make an appointment to change the appointment period
Fubitai Vaccine｜News: You can make an appointment in the middle of this week. Fosun BioNTech Vaccine will be available from the weekend
New Coronary Pneumonia New Coronary Vaccine BioNTech/Fosun Vaccine